ARMISTICE CAPITAL, LLC - 30 Sep 2025 SCHEDULE 13G/A Report for Verrica Pharmaceuticals Inc. Common Stock, $0.0001 par value (VRCA)

Filing Manager: ARMISTICE CAPITAL, LLC
Reporting Manager: Armistice Capital, LLC
Security: Verrica Pharmaceuticals Inc. Common Stock, $0.0001 par value
Symbol: VRCA
Shares outstanding: 9,441,551 shares
Disclosed Ownership: 639,193 shares
Ownership: 6.8%
Form type: SCHEDULE 13G/A
Filing time: 14 Nov 2025, 18:29:46 UTC
Date of event: 30 Sep 2025
Next filing: 17 Feb 2026
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Armistice Capital, LLC	6.8%	639,193	0	639,193	/s/ Steven Boyd	Steven Boyd - Managing Member
Steven Boyd	6.8%	639,193	0	639,193	/s/ Steven Boyd	Steven Boyd